Alexander Mironov, Vice President Business Development, leads identification, evaluation, and negotiation of business opportunities that meet Alvogen‘s inorganic growth criteria.
Alexander‘s brand pharmaceuticals experience lends to his additional focus on acquiring revenue generating companies and products for the branded division of Alvogen, Almatica Pharma.
Prior to joining Alvogen, Alexander held similar business development roles with Inspirion Pharmaceuticals and Kirax Corporation.
Earlier experience included VP of Project and Regulatory Management at NexGenix Pharmaceuticals, Sr. Director of Regulatory Affairs at EKR Therapeutics (acquired by Cornerstone Therapeutics), Associate Director of Regulatory Affairs with Esprit Pharma (acquired by Allergan), Manager at Valera Pharmaceuticals (acquired by Indevus Pharmaceuticals). Alex was also affiliated with Pfizer, Inc. and Ranbaxy Pharmaceuticals.
Mr. Mironov earned a B.S. in Biochemistry from Rutgers University and completed Executive Management Training in Private Equity/ Venture Capital at Harvard Business School.